Early research (Phase 1)Study completedNCT02135276
What this trial is testing
A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects
Who this might be right for
End Stage Renal Disease
Tetraphase Pharmaceuticals, Inc 12